Mirae Asset Global Investments
BNGO icon

Mirae Asset Global Investments’s Bionano Genomics BNGO Stock Holding History

Mirae Asset Global Investments’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,411
Closed -$620K – 2534
2023
Q3 		$620K Buy
3,411
+133
+4% +$34.8K ﹤0.01% 1780
2023
Q2 		$1.2M Buy
3,278
+378
+13% +$171K ﹤0.01% 1460
2023
Q1 		$1.93M Sell
2,900
-14
-0.5% -$12.4K ﹤0.01% 1220
2022
Q4 		$2.55M Buy
2,914
+647
+29% +$814K 0.01% 1041
2022
Q3 		$2.49M Buy
2,267
+259
+13% +$342K 0.01% 1042
2022
Q2 		$1.66M Buy
+2,008
New +$2.07M ﹤0.01% 1202

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Mirae Asset Global Investments's BNGO Position: Q4 2023 in Review

Mirae Asset Global Investments sold out of Bionano Genomics (BNGO) in Q4 2023, closing a stake of 3,411 shares — an estimated $620K sold.

Mirae Asset Global Investments first reported a position in BNGO in Q2 2022 and held it in 6 quarters. The position peaked at $2.55M in Q4 2022. 62 funds tracked by Wall St. Rank hold BNGO as of Q4 2023.

  • Mirae Asset Global Investments reported no remaining Bionano Genomics position as of Q4 2023 after selling out during the quarter.
  • Mirae Asset Global Investments sold 3,411 Bionano Genomics shares in Q4 2023, an estimated $620K.
  • Mirae Asset Global Investments first reported a position in Bionano Genomics in Q2 2022 and held it in 6 quarters.
  • Mirae Asset Global Investments's Bionano Genomics position peaked at $2.55M in Q4 2022.
  • 62 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2023.

Based on Mirae Asset Global Investments's 13F filing for Q4 2023, filed 24 Jan 2024.